Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Sanson

Showing results (101-110 of 290) with videos related to

Pageof 29
Sort By:
Neuro-Oncology|October 18, 2012
Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomasAgustí Alentorn, Yannick Marie, Catherine Carpentier, et al.
Brain : a Journal of Neurology|December 13, 2002
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patientsJean-Sébastien Guillamo, Alain Créange, Chantal Kalifa, et al.
The Oncologist|January 4, 2021
Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic ChallengesCristina Birzu, Suzanne Tran, Franck Bielle, et al.
Cancer|January 20, 2011
Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951Karima Mokhtari, François Ducray, Johan M Kros, et al.
Cancer|March 29, 2006
Prognostic impact of molecular markers in a series of 220 primary glioblastomasCaroline Houillier, Julie Lejeune, Alexandra Benouaich-Amiel, et al.
Journal of Neurosurgery|April 22, 2004
Prognostic value of allelic losses and telomerase activity in meningiomasPascal Leuraud, Edouard Dezamis, Lucinda Aguirre-Cruz, et al.
Cancer Investigation|January 7, 2016
Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent GlioblastomaMarianne Labussière, Caroline Cheneau, Claudia Prahst, et al.
Neuro-Oncology|February 7, 2019
Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopyFrancesca Branzoli, Clément Pontoizeau, Lucien Tchara, et al.
Acta Neuropathologica Communications|December 20, 2025
Functional analysis of telomere maintenance mechanisms is more informative than immunohistochemistry for ATRX mutation interpretation in GliomasClemence Guerriau, Camille Léonce, Catherine Carpentier, et al.
Acta Neuropathologica Communications|April 3, 2016
Characteristics of gliomas in patients with somatic IDH mosaicismCharlotte Bonnet, Laure Thomas, Dimitri Psimaras, et al.
Pageof 29

Showing results (101-110 of 290) with videos related to

Sort By:
Pageof 29
Neuro-Oncology|October 18, 2012
Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomasAgustí Alentorn, Yannick Marie, Catherine Carpentier, et al.
Brain : a Journal of Neurology|December 13, 2002
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patientsJean-Sébastien Guillamo, Alain Créange, Chantal Kalifa, et al.
The Oncologist|January 4, 2021
Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic ChallengesCristina Birzu, Suzanne Tran, Franck Bielle, et al.
Cancer|January 20, 2011
Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951Karima Mokhtari, François Ducray, Johan M Kros, et al.
Cancer|March 29, 2006
Prognostic impact of molecular markers in a series of 220 primary glioblastomasCaroline Houillier, Julie Lejeune, Alexandra Benouaich-Amiel, et al.
Journal of Neurosurgery|April 22, 2004
Prognostic value of allelic losses and telomerase activity in meningiomasPascal Leuraud, Edouard Dezamis, Lucinda Aguirre-Cruz, et al.
Cancer Investigation|January 7, 2016
Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent GlioblastomaMarianne Labussière, Caroline Cheneau, Claudia Prahst, et al.
Neuro-Oncology|February 7, 2019
Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopyFrancesca Branzoli, Clément Pontoizeau, Lucien Tchara, et al.
Acta Neuropathologica Communications|December 20, 2025
Functional analysis of telomere maintenance mechanisms is more informative than immunohistochemistry for ATRX mutation interpretation in GliomasClemence Guerriau, Camille Léonce, Catherine Carpentier, et al.
Acta Neuropathologica Communications|April 3, 2016
Characteristics of gliomas in patients with somatic IDH mosaicismCharlotte Bonnet, Laure Thomas, Dimitri Psimaras, et al.
Pageof 29